Giving TuesdayDonate To This Campaign
Join the Movement and Set the Pace to End Cancer.
Tomorrow is Giving Tuesday, a global movement dedicated to giving back, and we are asking you to join this movement and give back to Paceline. 100% of every dollar raised supports critical research and survivorship at the Georgia Cancer Center.
Each year, Paceline hosts a bike ride for hundreds of participants who are pedaling toward a common goal: cure cancer faster, together. Similar to the idea behind Giving Tuesday, when the Paceline community comes together, tremendous impact occurs.
The pandemic has changed and impacted everything this year. Due to the pandemic, Paceline was unable to have our annual cycling event this year. Cancer research has been negatively impacted by COVID-19. However, cancer doesn't stop; therefore, Paceline won't stop either. In lieu of a physical event, Paceline had its first virtual event on October 24, 2020, raising more than $120k for research at the Georgia Cancer Center.
From our inaugural event, a physical ride in May 2019, Paceline's participants raised over $200k, which was granted to three areas of research at the Georgia Cancer Center:
Major Equipment Award
Dr. Han-Fei Ding
Dr. Ding’s recommendation for the purchase of an Amersham ImageQuant 800 (IQ800) imager has been approved for funding for $50,000. This imaging system provides high-resolution quantitative analyses for multiple sample types, and its highly sensitive detection capabilities automatically optimize the best signal-to-noise ratio when analyzing gels and blots.
Translational Research Award II
Drs. Huidong Shi and Ravindra Kolhe
Their project, “Cellular heterogeneity and tumor microenvironment in triple negative breast cancer disparities,” will receive up to $75,000 upon receipt and review of a full proposal. Using single cell RNA sequencing technology, this research will address the disparity observed in triple negative breast cancer prevalence and treatment outcomes for African American versus Caucasian women.
Early Career Researcher Award
Dr. Zhi-Chun Ding
Dr. Ding’s project, “Targeting IFNg-induced CD4+ T Cell Exhaustion to Potentiate Cancer Immunotherapy,” was selected as the top-ranking proposal, to receive up to $75,000. Dr. Ding’s research aims to improve the efficacy of adoptive T-cell transfer (ACT) cancer therapeutic regimens, which rely on functional CD8+ and CD4+ T cells. Using a novel model system, Dr. Ding will focus on overcoming one limitation of ACT: tumor-induced CD4+ T cell exhaustion.
This Giving Tuesday, our goal is to continue to raise critical funds to make a difference in the research abilities for the Georgia Cancer Center and further their mission to reduce the burden of cancer in the State of Georgia and around the globe. Your support will make a direct impact as we set the pace to end cancer. Together, we can cure cancer faster.